Sanofi India Limited
SBI Mutual Fund trimmed its stake in Sanofi India from 1.73% to 1.09%, selling 1,47,988 shares.
A leading multinational pharmaceutical company operating in India, Sanofi India manufactures and distributes medicines across multiple therapeutic areas including diabetes, cardiology, thrombosis, central nervous system disorders, and anti-histamines. The company serves patients and healthcare providers through a comprehensive portfolio of pharmaceutical products designed to address diverse medical conditions. Its established presence in India's pharmaceutical market reflects its commitment to improving health outcomes across the country.
India's largest AMC by total AUM, managing over Rs 11 lakh crore across equity, debt and hybrid schemes. Backed by State Bank of India, the country's largest bank, which gives it unmatched retail reach across every Indian state. With over 70 schemes and 50 million folios, SBI MF's positioning moves are tracked as a proxy for domestic institutional flows.